Antu Biotech's announcement on adjusting the upper limit of the share repurchase price after implementing the 2023 equity distribution

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.